Quanterix Corp (QTRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Quanterix Corp (QTRX) has a cash flow conversion efficiency ratio of 0.011x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.59 Million) by net assets ($237.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Quanterix Corp (QTRX) market capitalisation for the company's overall valuation and market capitalisation.
Quanterix Corp - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Quanterix Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Quanterix Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Quanterix Corp ranked by their cash flow conversion efficiency. Explore Quanterix Corp (QTRX) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Black Mammoth Metals Corp
V:BMM
|
-0.010x |
|
Wam Research Ltd
AU:WAX
|
0.017x |
|
ABL Group ASA
OL:ABL
|
0.040x |
|
Reyon Pharmaceutical Co Ltd
KO:102460
|
-0.007x |
|
Ge Shen Corporation Bhd
KLSE:7197
|
-0.021x |
|
Jindal Photo Limited
NSE:JINDALPHOT
|
0.009x |
|
Dong Phu Rubber JSC
VN:DPR
|
0.036x |
|
New Best Wire Industrial Co Ltd
TWO:5013
|
0.007x |
Annual Cash Flow Conversion Efficiency for Quanterix Corp (2015–2025)
The table below shows the annual cash flow conversion efficiency of Quanterix Corp from 2015 to 2025. View Quanterix Corp (QTRX) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $295.73 Million | $-77.24 Million | -0.261x | -145.13% |
| 2024-12-31 | $330.04 Million | $-35.16 Million | -0.107x | -97.26% |
| 2023-12-31 | $349.96 Million | $-18.90 Million | -0.054x | +59.95% |
| 2022-12-31 | $357.93 Million | $-48.27 Million | -0.135x | -24.13% |
| 2021-12-31 | $440.95 Million | $-47.91 Million | -0.109x | +4.15% |
| 2020-12-31 | $206.12 Million | $-23.36 Million | -0.113x | +44.31% |
| 2019-12-31 | $128.66 Million | $-26.19 Million | -0.204x | +70.55% |
| 2018-12-31 | $41.56 Million | $-28.72 Million | -0.691x | -105.93% |
| 2017-12-31 | $65.87 Million | $-22.11 Million | -0.336x | +74.51% |
| 2016-12-31 | $13.48 Million | $-17.74 Million | -1.317x | -259.82% |
| 2015-12-31 | $-15.20 Million | $-12.52 Million | 0.824x | -- |
About Quanterix Corp
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measureme… Read more